Showing results (31-40 of 42) with videos related to

Sort By:
Pageof 5
Oncotarget|October 6, 2015
The lincRNA HOTAIRM1, located in the HOXA genomic region, is expressed in acute myeloid leukemia, impacts prognosis in patients in the intermediate-risk cytogenetic category, and is associated with a distinctive microRNA signatureMarina Díaz-Beyá, Salut Brunet, Josep Nomdedéu, et al.
Transplantation and Cellular Therapy|May 16, 2022
PTCY and Tacrolimus for GVHD Prevention for Older Adults Undergoing HLA-Matched Sibling and Unrelated Donor AlloHCTMaría Queralt Salas, Paola Charry, Alexandra Pedraza, et al.
Transplantation and Cellular Therapy|December 2, 2023
Post-Transplantation Cyclophosphamide and Tacrolimus for Graft-versus-Host Disease Prevention after Allogeneic Hematopoietic Cell Transplantation from HLA-Matched Donors Has More Advantages Than LimitationsMaría Queralt Salas, Alexandra Pedraza, Paola Charry, et al.
British Journal of Haematology|April 26, 2013
Response to lenalidomide in myelodysplastic syndromes with del(5q): influence of cytogenetics and mutationsMar Mallo, Mónica Del Rey, Mariam Ibáñez, et al.
Transplantation and Cellular Therapy|September 11, 2022
Bacterial Bloodstream Infections in Patients Undergoing Allogeneic Hematopoietic Cell Transplantation With Post-Transplantation CyclophosphamideMaría Queralt Salas, Paola Charry, Pedro Puerta-Alcalde, et al.
Cytotherapy|November 12, 2023
Endothelial Activation and Stress Index in adults undergoing allogeneic hematopoietic cell transplantation with post-transplant cyclophosphamide-based prophylaxisSilvia Escribano-Serrat, Luis Gerardo Rodríguez-Lobato, Paola Charry, et al.
JHEP Reports : Innovation in Hepatology|April 16, 2026
Prognostic value of factor VIII, D-dimer and high molecular risk variants assessing re-thrombosis risk in non-cirrhotic portal vein thrombosisAnna Baiges, Bogdan Procopet, Luis Téllez, et al.
Blood Advances|December 1, 2022
Incidence, risk factors, and impact of early cardiac toxicity after allogeneic hematopoietic cell transplantAmanda Isabel Pérez-Valencia, Enric Cascos, Sara Carbonell-Ordeig, et al.
Genes, Chromosomes & Cancer|May 21, 2013
Reciprocal translocations in myelodysplastic syndromes and chronic myelomonocytic leukemias: review of 5,654 patients with an evaluable karyotypeDolors Costa, Concha Muñoz, Ana Carrió, et al.
Leukemia Research|November 10, 2017
Clinical and biological significance of isolated Y chromosome loss in myelodysplastic syndromes and chronic myelomonocytic leukemia. A report from the Spanish MDS GroupMeritxell Nomdedeu, Arturo Pereira, Xavier Calvo, et al.
Pageof 5